Drugs / Transdermal estradiol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06610305 | Sep 2024 → Jun 2028 expected | major depressive disorder | University of North Carolina, Chapel Hill | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Transdermal estradiol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06610305 ↗ |